title: [Multicentre clinical trials: degree of homogeneity in the ethical-scientific review performed by research ethics committees].
authors.affiliation: Departamento Médico, GlaxoSmithKline S.A., Tres Cantos, Madrid, Spain. rafael.dal-re@gsk.com
authors.forename: Rafael
authors.initials: R
authors.lastname: Dal-Ré
authors.forename: Alejandro
authors.initials: A
authors.lastname: Pedromingo
authors.forename: Elena
authors.initials: E
authors.lastname: Morejón
authors.forename: Isabel
authors.initials: I
authors.lastname: Luque
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D002219:Carbamates; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000941:ethics*; D017326:Clinical Trials, Phase III as Topic; D032962:Consent Forms; D028744:Ethics Committees, Research; D005663:Furans; D006801:Humans; D015337:Multicenter Studies as Topic / Q000941:ethics*; D010755:Organophosphates / Q000627:therapeutic use; D013030:Spain; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D002219:Carbamates; D005663:Furans; D010755:Organophosphates; D013449:Sulfonamides; C426859:fosamprenavir